Neurocrine Biosciences, Inc. annual revenue for fiscal 2025 was $2.9 billion, an increase of 21.4% from $2.4 billion in fiscal 2024. All figures are reported results from public filings — no estimates or projections.
| Revenue (annual) | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $2.9B | $2.4B | $1.9B | $1.5B | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Revenue (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $814M | $806M | $795M | $688M | $573M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More NBIX metrics: Gross Profit · Operating Income · Net Income · EPS · Free Cash Flow
All NBIX financial statements → Interactive NBIX charts →
About TickerBase · Data methodology & sources